A human being's health is priceless but has a cost

In the context of cancer treatment, Tunisia annually allocates over 150 million Tunisian dinars(MDT) for the import of anticancer medications. This is a bill that is becoming increasingly heavy over time. The establishment of NEAPOLIS PHARMA has come to address this urgent national need to prevent any risk of future stock shortages, in addition to enabling significant savings in foreign currency for the Central Pharmacy.